#Latest news with #KEYNOTEA18Medscape21-05-2025HealthMedscapeConference MDAngle: ASCO 2025 Endometrial and Related CancerPreconference Considerations ASCO 2025: A Preview of Advancements in Endometrial Cancer Dr Matulonis previews key updates in gynecologic cancers, with a focus on endometrial cancer. She notes promising data from a phase 2 trial of benmelstobart plus chemotherapy, as well as results from the DUO-E and FRUSICA-1 studies. Dr Matulonis also looks forward to phase 3 results in ovarian and cervical cancers, including the KEYNOTE-A18 and ROSELLA studies. Quick Clinical Takeaways Coming soon: Dr Matulonis highlights new data and progress regarding endometrial and related cancers immediately following ASCO. How Will My Patients Benefit? Coming soon: Reflections from Dr Matulonis on how new data from ASCO will affect her patients with endometrial and related cancers. Lead image: Medscape
Medscape21-05-2025HealthMedscapeConference MDAngle: ASCO 2025 Endometrial and Related CancerPreconference Considerations ASCO 2025: A Preview of Advancements in Endometrial Cancer Dr Matulonis previews key updates in gynecologic cancers, with a focus on endometrial cancer. She notes promising data from a phase 2 trial of benmelstobart plus chemotherapy, as well as results from the DUO-E and FRUSICA-1 studies. Dr Matulonis also looks forward to phase 3 results in ovarian and cervical cancers, including the KEYNOTE-A18 and ROSELLA studies. Quick Clinical Takeaways Coming soon: Dr Matulonis highlights new data and progress regarding endometrial and related cancers immediately following ASCO. How Will My Patients Benefit? Coming soon: Reflections from Dr Matulonis on how new data from ASCO will affect her patients with endometrial and related cancers. Lead image: Medscape
21-05-2025
